Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients

Eur J Neurol. 2020 Feb;27(2):384-391. doi: 10.1111/ene.14089. Epub 2019 Oct 20.

Abstract

Background and purpose: There are few clinico-radiological data on optic neuritis (ON) with myelin oligodendrocyte glycoprotein antibody (MOG-IgG). The objective was to characterize the clinico-radiological phenotype and outcome of patients with MOG-IgG-related ON.

Methods: The records of all adult patients admitted in three medical centres with MOG-IgG-associated ON who underwent orbital and brain magnetic resonance imaging (MRI) at the acute phase were reviewed. Spinal cord MRI within 1 month from the ON and all of the follow-up MRI were reviewed.

Results: Of 62 patients, 41.9% had bilateral ON and 66.2% optic disc swelling. On initial MRI, lesions were anterior (92%), extensive (63%) and associated with optic perineuritis (46.6%). Silent brain lesions were found in 51.8% of patients but were mainly non-specific (81%). Of 39 individuals with spinal MRI at onset, nine had abnormal findings (four were asymptomatic). Two symptomatic patients had longitudinally extensive myelitis with concurrent H-sign. At last follow-up, 5% of patients had visual acuity ≤0.1. Brain MRI remained unchanged in 41 patients (87%).

Conclusions: Our study supports a mostly benign ophthalmological course of MOG-IgG-associated ON, despite initially longitudinally extensive lesions and development of optic nerve atrophy on orbital MRI. Spinal MRI could be of interest in detecting silent suggestive lesions.

Keywords: MRI; follow-up; myelin oligodendrocyte glycoprotein; optic neuritis.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Autoantibodies
  • Follow-Up Studies
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Myelitis*
  • Optic Neuritis* / diagnostic imaging

Substances

  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein